Santa Sp. z o.o.
- Address
- lock Available on a paid plan
Ophthalmology and Thyroid Eye Disease
At Santa Sp. z o.o. in Lodz, a strong focus is placed on eye diseases, especially thyroid eye disease and neovascular age-related macular degeneration. These studies are designed to test new treatment options, assess safety, and improve outcomes for vision-threatening conditions.
- Testing emerging therapies for thyroid eye disease and related eye inflammation
- Comparing treatments for neovascular age-related macular degeneration to support better vision care
- Evaluating whether new ophthalmic approaches can improve symptoms and disease control
Research here also includes long-term safety work in diabetic eye disease, reflecting the site’s broader interest in protecting vision in people with chronic metabolic conditions.
Respiratory and Allergy Research
This site conducts extensive trials in respiratory tract diseases and immune system diseases, with major attention to asthma, allergic rhinitis, and chronic rhinosinusitis with nasal polyps. The overall aim is to improve symptom control, reduce flare-ups, and assess new allergy-focused therapies.
- Studying treatments for asthma, including severe and eosinophilic forms
- Evaluating therapies for seasonal and perennial allergic rhinitis and pollen-related symptoms
- Testing options for chronic rhinosinusitis with nasal polyps to ease congestion and improve quality of life
The research portfolio at Santa Familia PTG Łódź also includes trials in bronchiectasis and other chronic airway disorders, highlighting a broad commitment to respiratory care.
Dermatology and Immune-Mediated Skin Conditions
Another major area of activity is skin and connective tissue diseases, particularly atopic dermatitis, prurigo nodularis, hidradenitis suppurativa, and chronic spontaneous urticaria. These studies focus on reducing itching, calming inflammation, and improving everyday comfort for patients with persistent skin disease.
- Assessing new treatments for atopic dermatitis and related eczema conditions
- Exploring therapies for prurigo nodularis to relieve itch and skin lesions
- Evaluating options for hidradenitis suppurativa and urticaria to better control inflammatory skin symptoms
These trials reflect a broader interest in immune-mediated disease, with the goal of offering more effective and better-tolerated care.
Cardiovascular and Metabolic Disease Studies
The site has a substantial portfolio in cardiovascular diseases and nutritional and metabolic diseases, including heart failure, atrial fibrillation, hypertension, type 2 diabetes, obesity, and metabolic dysfunction-associated steatotic liver disease. The main purpose is to evaluate new strategies that may reduce risk, improve control, and support long-term health.
- Testing therapies for heart failure and prevention of worsening cardiovascular outcomes
- Studying treatments for atrial fibrillation and broader atherosclerotic cardiovascular disease
- Investigating metabolic care in type 2 diabetes, obesity, and fatty liver disease
These studies combine prevention and treatment goals, showing a clear interest in lowering the burden of chronic cardiometabolic illness.
Gastroenterology, Liver Disease, and Inflammatory Bowel Conditions
Clinical research at the site also covers digestive system diseases, especially Crohn's disease, ulcerative colitis, and metabolic dysfunction-associated steatohepatitis. The trials aim to improve disease control, support liver health, and evaluate longer-term treatment effects.
- Assessing therapies for Crohn's disease and ulcerative colitis
- Studying treatment approaches for MASH and liver fibrosis
- Exploring whether new medicines can help reduce inflammation and protect organ function
These investigations show an emphasis on chronic inflammatory conditions that can significantly affect daily life and long-term outcomes.
Nervous System and Pain Research
Trials in nervous system diseases and pain-related conditions include epilepsy, neuropathic pain, and chronic low back pain. The research is centered on improving symptom control, lowering seizure frequency, and finding better pain-relief options.
- Evaluating treatments for epilepsy, including refractory and generalized forms
- Studying therapies for neuropathic pain and painful nerve disorders
- Assessing new approaches for chronic low back pain and related functional limitations
Overall, the work in this area seeks to improve daily functioning and quality of life for people living with long-term neurological and pain conditions.
Musculoskeletal and Rheumatologic Conditions
The site also participates in research on musculoskeletal diseases, including psoriatic arthritis and osteoarthritis, as well as systemic inflammatory disorders such as systemic lupus erythematosus and systemic sclerosis. These studies are intended to evaluate new ways to reduce inflammation, pain, and joint-related disability.
- Testing therapies for psoriatic arthritis and other inflammatory joint diseases
- Studying treatment options for osteoarthritis to improve mobility and comfort
- Exploring broader immune-based approaches for systemic lupus erythematosus and systemic sclerosis
This area adds to the site’s broad profile in chronic disease research, with a strong emphasis on inflammation-driven conditions.
Other Specialty Areas
In addition to its main therapeutic focuses, the research portfolio at Santa Sp. z o.o. includes studies in otolaryngologic diseases, respiratory tract diseases, and selected eye diseases linked to allergy, inflammation, and chronic illness. These trials are designed to refine diagnosis, improve symptom relief, and test new treatment strategies across several overlapping specialties.
- Investigating allergy-related conditions affecting the nose, eyes, and airways
- Supporting better diagnosis and management of chronic inflammatory disorders
- Assessing treatment effectiveness across multiple long-term disease areas
With 72 clinical trials and 19 investigators, the site shows a wide and active research profile across many common and complex diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 13 therapeutic areas and 15 of 97 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 95 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 26 by active trials.
lock +25 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +19 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Santa Sp. z o.o.
lock Showing 1 of 78 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (20321) An open-label, single arm, roll-over study to provide continued treatment with darolutamide in participants who were enrolled in previous Bayer sponsored studies | Bayer Consumer Care AG | Phase III | Not Recruiting | Oct 2020 | — |
IMP list
lock Showing 1 of 97 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Itepekimab | 4 | Unknown | 2024-06-18 | 2026-06-23 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.